Kingsview Wealth Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,427	Closed	-$73.4K	–	933
2023 Q2	$73.4K	Hold	10,427	–	–	﹤0.01%	885
2023 Q1	$87K	Buy	10,427 +150	+1%	+$1.25K	﹤0.01%	858
2022 Q4	$118K	Hold	10,277	–	–	0.01%	815
2022 Q3	$129K	Buy	+10,277	New	+$129K	0.01%	785